|
PT2121578T
(pt)
*
|
2007-01-12 |
2016-11-14 |
Novartis Ag |
Processo de preparação de ácido 5-bifenil-4-amino-2-metil-pentanoico
|
|
PE20091364A1
(es)
|
2008-01-17 |
2009-10-13 |
Novartis Ag |
Proceso para la preparacion de inhibidores de nep
|
|
AU2012202949B2
(en)
*
|
2008-01-17 |
2015-01-22 |
Novartis Ag |
Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
|
|
JP5420761B2
(ja)
|
2009-05-28 |
2014-02-19 |
ノバルティス アーゲー |
ネプリリシン阻害剤としての置換アミノプロピオン酸誘導体
|
|
KR20120041702A
(ko)
|
2009-05-28 |
2012-05-02 |
노파르티스 아게 |
네프릴리신 억제제로서의 치환된 아미노부티르산 유도체
|
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
|
HRP20151061T1
(hr)
*
|
2010-01-22 |
2015-12-04 |
Novartis Ag |
Posrednici inhibitora neutralne endopeptidaze i postupak njihove pripreme
|
|
JP5705984B2
(ja)
|
2010-08-23 |
2015-04-22 |
ノバルティス アーゲー |
Ｎｅｐ阻害剤を製造するための中間体の調製方法
|
|
WO2012025502A1
(en)
*
|
2010-08-23 |
2012-03-01 |
Novartis Ag |
New process for the preparation of intermediates useful for the manufacture nep inhibitors
|
|
US8993631B2
(en)
|
2010-11-16 |
2015-03-31 |
Novartis Ag |
Method of treating contrast-induced nephropathy
|
|
US8877815B2
(en)
*
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
|
SG191175A1
(en)
|
2010-12-15 |
2013-07-31 |
Theravance Inc |
Neprilysin inhibitors
|
|
EP2651896B1
(en)
|
2010-12-15 |
2015-08-12 |
Theravance Biopharma R&D IP, LLC |
Neprilysin inhibitors
|
|
WO2012154249A1
(en)
|
2011-02-17 |
2012-11-15 |
Theravance, Inc. |
Substituted aminobutyric derivatives as neprilysin inhibitors
|
|
CN103380119B
(zh)
|
2011-02-17 |
2016-02-17 |
施万生物制药研发Ip有限责任公司 |
作为脑啡肽酶抑制剂的经取代的氨基丁酸衍生物
|
|
CN103596928B
(zh)
|
2011-05-31 |
2017-02-15 |
施万生物制药研发Ip有限责任公司 |
脑啡肽酶抑制剂
|
|
US9499487B2
(en)
|
2011-05-31 |
2016-11-22 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
|
CA2835281A1
(en)
|
2011-05-31 |
2012-12-06 |
Theravance, Inc. |
Neprilysin inhibitors
|
|
TWI560172B
(en)
*
|
2011-11-02 |
2016-12-01 |
Theravance Biopharma R&D Ip Llc |
Neprilysin inhibitors
|
|
TWI562986B
(en)
*
|
2012-02-15 |
2016-12-21 |
Theravance Biopharma R&D Ip Llc |
Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
|
|
CA2871292A1
(en)
|
2012-05-31 |
2013-12-05 |
Theravance Biopharma R&D Ip, Llc |
Nitric oxide donor neprilysin inhibitors
|
|
BR112014030743B1
(pt)
|
2012-06-08 |
2022-09-06 |
Theravance Biopharma R&D Ip, Llc |
Composto inibidor de neprilisina, processo para a preparação do referido composto, composição farmacêutica e uso do referido composto
|
|
ES2710932T3
(es)
|
2012-06-08 |
2019-04-29 |
Theravance Biopharma R&D Ip Llc |
Inhibidores de neprilisina
|
|
KR102104954B1
(ko)
|
2012-08-08 |
2020-04-27 |
세라밴스 바이오파마 알앤디 아이피, 엘엘씨 |
네프릴리신 억제제
|
|
WO2014126979A1
(en)
|
2013-02-14 |
2014-08-21 |
Novartis Ag |
Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
|
|
KR20150119107A
(ko)
|
2013-02-14 |
2015-10-23 |
노파르티스 아게 |
개선된 생체내 효능을 갖는 nep 억제제로서의 치환된 비스페닐 부탄산 유도체
|
|
HUE034210T2
(hu)
|
2013-03-05 |
2018-02-28 |
Theravance Biopharma R&D Ip Llc |
Neprilizininhibitorok
|
|
CN104230865B
(zh)
*
|
2013-06-13 |
2018-01-09 |
上海翰森生物医药科技有限公司 |
联芳基取代的4‑氨基丁酸衍生物及其制备方法和用途
|
|
CA2934936A1
(en)
|
2014-01-30 |
2015-08-06 |
Theravance Biopharma R&D Ip, Llc |
Neprilysin inhibitors
|
|
MX2016009759A
(es)
|
2014-01-30 |
2016-11-17 |
Theravance Biopharma R&D Ip Llc |
Inhibidores de neprilisina.
|
|
EP3218351B1
(en)
|
2014-11-14 |
2019-06-19 |
Zentiva K.S. |
A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377
|
|
WO2016086798A1
(zh)
*
|
2014-12-03 |
2016-06-09 |
上海翰森生物医药科技有限公司 |
Nep抑制剂结晶型游离酸、钙盐多晶型及其制备方法和应用
|
|
CN104557600B
(zh)
*
|
2015-01-26 |
2016-05-04 |
苏州明锐医药科技有限公司 |
沙库比曲的制备方法
|
|
MY187899A
(en)
|
2015-02-11 |
2021-10-27 |
Theravance Biopharma R&D Ip Llc |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
|
|
TW201632493A
(zh)
|
2015-02-13 |
2016-09-16 |
諾華公司 |
新穎方法
|
|
LT3259255T
(lt)
|
2015-02-19 |
2021-04-26 |
Theravance Biopharma R&D Ip, Llc |
(2r,4r)-5-(5`-chlor-2`-fluorbifenil-4-il)-2-hidroksi-4-[(5-metiloksazol-2-karbonil)amino]pentano rūgštis
|
|
WO2016135751A1
(en)
|
2015-02-25 |
2016-09-01 |
Mylan Laboratories Limited |
Novel process for the preparation of sacubitril and its intermediates
|
|
CN106187808A
(zh)
*
|
2015-05-08 |
2016-12-07 |
苏州鹏旭医药科技有限公司 |
Ahu-377的制备方法、ahu-377中间体及ahu-377中间体的制备方法
|
|
CN104926707B
(zh)
*
|
2015-05-12 |
2017-10-27 |
江苏福瑞生物医药有限公司 |
一种药物中间体的合成方法
|
|
CN104829514B
(zh)
*
|
2015-05-12 |
2017-10-03 |
江苏福瑞生物医药有限公司 |
一种药物中间体的合成方法
|
|
CN104860894B
(zh)
*
|
2015-06-10 |
2017-05-17 |
北京博全健医药科技有限公司 |
一种抗心衰药lcz696的制备方法
|
|
WO2016203500A2
(en)
*
|
2015-06-19 |
2016-12-22 |
Actavis Group Ptc Ehf. |
Preparation of sacubitril or salt thereof and novel intermediates in the preparation of sacubitril
|
|
US11786498B2
(en)
*
|
2015-07-02 |
2023-10-17 |
Novartis Ag |
Sacubitril calcium salts
|
|
WO2017006254A1
(en)
|
2015-07-08 |
2017-01-12 |
Novartis Ag |
Drug combination comprising an angiotensin ii receptor antagonist, a neutral endopeptidase inhibitor and a mineralcorticoid receptor antagonist
|
|
CN105061263B
(zh)
*
|
2015-08-11 |
2017-03-15 |
苏州楚凯药业有限公司 |
一种nep抑制剂中间体的制备方法
|
|
CN105168205A
(zh)
*
|
2015-08-18 |
2015-12-23 |
泰力特医药（湖北）有限公司 |
一种血管紧张素ii受体和脑啡肽酶受体双重抑制剂lcz696的制备方法
|
|
WO2017033128A1
(en)
|
2015-08-25 |
2017-03-02 |
Novartis Ag |
Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
|
|
CN105130869B
(zh)
*
|
2015-09-07 |
2017-12-26 |
曾伟 |
一种Entresto中间体(S)‑5‑(联苯‑4‑羰基)吡咯烷‑2‑酮的合成方法
|
|
WO2017051326A1
(en)
|
2015-09-23 |
2017-03-30 |
Novartis Ag |
New processes and intermediates useful in synthesis of nep inhibitors
|
|
CN105348209B
(zh)
|
2015-12-09 |
2017-12-26 |
浙江天宇药业股份有限公司 |
一种抗心衰药lcz696的制备方法
|
|
CN105523964B
(zh)
*
|
2015-12-09 |
2017-05-24 |
苏州楚凯药业有限公司 |
一种抗心衰药物中间体的制备方法
|
|
CN108602785B
(zh)
|
2015-12-10 |
2023-08-11 |
诺华股份有限公司 |
新的工艺和中间体
|
|
MX2018007129A
(es)
|
2015-12-11 |
2018-11-09 |
Zentiva Ks |
Formas solidas de ester etilico del acido (2r,4s)-5-(bifenil-4-il) -4-[(3-carboxipropionil)amino]-2-metil-pentanoico, sus sales y un metodo de preparacion.
|
|
CN106977415B
(zh)
*
|
2016-01-15 |
2021-03-26 |
广东东阳光药业有限公司 |
一种沙库必曲的中间体及其制备方法
|
|
CN105566194A
(zh)
*
|
2016-02-01 |
2016-05-11 |
张伯引 |
一种Sacubitril中间体的制备方法
|
|
WO2017148357A1
(zh)
*
|
2016-02-29 |
2017-09-08 |
广东东阳光药业有限公司 |
一种沙库必曲的中间体及其制备方法
|
|
KR20220035991A
(ko)
|
2016-03-08 |
2022-03-22 |
세라밴스 바이오파마 알앤디 아이피, 엘엘씨 |
(2s,4r)-5-(5'-클로로-2'-플루오로-[1,1'-비페닐]-4-일)-2-(에톡시메틸)-4-(3-히드록시이속사졸-5-카르복사미도)-2-메틸펜탄산 결정 및 그 용도
|
|
WO2017191620A1
(en)
*
|
2016-05-06 |
2017-11-09 |
Sun Pharmaceutical Industries Limited |
A crystalline form of a salt of sacubitril and a process of its preparation
|
|
CN105924355B
(zh)
*
|
2016-05-11 |
2018-08-17 |
浙江宏元药业有限公司 |
沙库比曲中间体及沙库比曲中间体和沙库比曲的制备方法
|
|
US20190256454A1
(en)
*
|
2016-07-05 |
2019-08-22 |
Novartis Ag |
New process for early sacubitril intermediates
|
|
CN107602399B
(zh)
*
|
2016-07-11 |
2020-09-25 |
江西东邦药业有限公司 |
一种脑啡肽酶抑制剂中间体的制备方法
|
|
JP6945619B2
(ja)
*
|
2016-08-17 |
2021-10-06 |
ノバルティス アーゲー |
Ｎｅｐ阻害剤合成のための新規な方法および中間体
|
|
CN106496055A
(zh)
*
|
2016-10-09 |
2017-03-15 |
杭州科巢生物科技有限公司 |
一种抗心衰新药的关键组分沙库比曲的新合成方法
|
|
EP3522886A4
(en)
*
|
2016-10-10 |
2020-02-19 |
Laurus Labs Limited |
STABLE AMORPHE FORM OF THE SACUBITRIL VALSARTAN TRINATRIUM COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
|
|
WO2018116203A1
(en)
|
2016-12-23 |
2018-06-28 |
Novartis Ag |
New process for early sacubitril intermediates
|
|
CN107311909A
(zh)
*
|
2017-06-22 |
2017-11-03 |
东南大学 |
一种lcz696杂质对照品的制备方法
|
|
CN109206419B
(zh)
*
|
2017-06-29 |
2023-07-14 |
上海迪赛诺化学制药有限公司 |
沙库比曲中间体及其制备方法和应用
|
|
RU2020122121A
(ru)
*
|
2017-12-05 |
2022-01-10 |
Басф Се |
Соли органических сульфокислот со сложными эфирами аминокислот и способ их получения
|
|
UY38072A
(es)
|
2018-02-07 |
2019-10-01 |
Novartis Ag |
Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
|
|
CN110407733A
(zh)
*
|
2018-04-26 |
2019-11-05 |
鲁南制药集团股份有限公司 |
一种沙库巴曲杂质化合物
|
|
CN110551151A
(zh)
*
|
2018-05-30 |
2019-12-10 |
微宏动力系统（湖州）有限公司 |
一种磷酸酯或亚磷酸酯的制备方法、电解液及二次电池
|
|
CN108727213B
(zh)
*
|
2018-06-29 |
2021-06-08 |
中国科学院上海有机化学研究所 |
一种沙库必曲的制备方法
|
|
WO2020039394A1
(en)
|
2018-08-24 |
2020-02-27 |
Novartis Ag |
New drug combinations
|
|
CN109456212A
(zh)
*
|
2018-12-03 |
2019-03-12 |
康化（上海）新药研发有限公司 |
一种沙库比曲中间体的合成方法
|
|
CN109400504A
(zh)
*
|
2018-12-11 |
2019-03-01 |
重庆三圣实业股份有限公司 |
Lcz696中间体非对映异构体的分离纯化方法
|
|
US11739052B2
(en)
|
2019-01-08 |
2023-08-29 |
Basf Se |
Process for the preparation of organosulfate salts of amino acids esters
|
|
CN109912486B
(zh)
*
|
2019-04-25 |
2022-09-27 |
东北制药集团股份有限公司 |
一种联苯甲基内酰胺化合物的制备方法
|
|
CN110878039A
(zh)
*
|
2019-12-18 |
2020-03-13 |
株洲千金药业股份有限公司 |
一种沙库巴曲缬沙坦钠杂质的制备方法
|
|
JP7064527B2
(ja)
*
|
2020-05-01 |
2022-05-10 |
ノバルティス アーゲー |
サクビトリルカルシウム塩
|
|
EP4178941B1
(en)
|
2020-07-09 |
2025-11-19 |
AdvanSix Resins & Chemicals LLC |
Branched amino acid surfactants
|
|
WO2022015604A1
(en)
|
2020-07-13 |
2022-01-20 |
Advansix Resins & Chemicals Llc |
Branched amino acid surfactants for personal care and cosmetic products
|
|
AU2021307397B2
(en)
|
2020-07-13 |
2024-06-13 |
Advansix Resins & Chemicals Llc |
Branched amino acid surfactants for use in healthcare products
|
|
EP4179029A2
(en)
|
2020-07-13 |
2023-05-17 |
AdvanSix Resins & Chemicals LLC |
Branched amino acid surfactants for inks, paints, and adhesives
|
|
EP4179038A1
(en)
|
2020-07-13 |
2023-05-17 |
AdvanSix Resins & Chemicals LLC |
Branched amino acid surfactants for oil and gas production
|
|
US12134748B2
(en)
|
2020-07-13 |
2024-11-05 |
Advansix Resins & Chemicals Llc |
Branched amino acid surfactants for cleaning products
|
|
CN116601275A
(zh)
|
2020-07-13 |
2023-08-15 |
艾德凡斯化学公司 |
用于电子产品的分支氨基酸表面活性剂
|
|
CN115677521B
(zh)
*
|
2022-11-16 |
2024-02-02 |
迪嘉药业集团股份有限公司 |
一种高纯度沙库巴曲钙的制备方法
|
|
CN117447341B
(zh)
*
|
2023-09-06 |
2025-11-18 |
杭州国瑞生物科技有限公司 |
一种沙库巴曲缬沙坦钠中间体的精制方法
|
|
CN117756622A
(zh)
*
|
2023-12-21 |
2024-03-26 |
安徽皓元药业有限公司 |
一种沙库巴曲关键中间体的制备方法
|